Technology Networks

Duquesne University, Agilent Establish Mass Spectrometry COE to Study Diseases, Environmental Issues
The new facility enables a wide range of research in the life sciences and environmental analysis.

Thermo Fisher Scientific and BrainMet Centre Collaborate on Dementia Research
The collaboration will advance dementia research by studying the effects of metals and metalloproteins in ageing and neurodegenerative diseases.

Agilent Announces Major Lab Software Suite, Fish DNA Analyzer, Food Collaboration, Transportable GC/MSD, and Single Quad LC/MS at Pittcon 2010
The company also announced a tool to facilitate third-party software control for Agilent LCs: OpenLAB Unified Software Suite.

Agilent and the National Center for Food Safety and Technology Collaborate to Develop Food Testing Methods
The collaboration will develop new scientific methods for food testing to solve problems facing global food supply chains.

Single stage reversed-phase liquid chromatography-mass spectrometry for the characterization of triglyceride positional isomers.
University Of York

The high level of selectivity afforded by RP-HPLC in combination with CID allowed recognition of eight groups of TAG positional isomers. Development of UPLC approach has reduced the run time by half while maintaining separation. The improved method combined with principal components analysis was used to assess the extent of variation of major TAGs in subcutaneous and intermuscular pork fat from four different locations of adipose tissues.

An improved data processing pipe-line for comprehensive H-NMR and X/MS -omics data
Dept. Analytical Chemistry

In the post acqusition analysis of comprehensive -omics data the pre-processing pipe-line is crucial to extract the maximum possible amount of information from the data. Here we show a processing pipe-line for (1D)H-NMR and (2D)X/MS data comprising; feature detection, inter-sample feature alignment and internal-standard free normalization that outperforms today’s state-of-the-art processing schemes.

Five noncovalent peptidic ligands show different affinity rankings in solution and gas phase
Institute for Research in Biomedicine (IRB), Barcelona Science Park, University of Barcelona, Spain

Stability of noncovalent complexes of VEGF protein with 5 peptidic ligands is studied. Experiments were conducted in solution (NMR CSP, ITC) and in gas phase (CID TOF MS). Each ligand differs from others in chirality of one amino acid. It was shown, that trend of stability of the studied noncovalent complexes is reversed in the gas phase relatively to the solution. An explanation of this behavior is presented.

Compound Management Technologist, St Jude Children's Research Hospital, Memphis, TN

St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. St. Jude is dedicated to providing unsurpassed patient care and to advancing the health of children through biomedical research.

Postdoctoral Research Associate
Northeastern University
The Center for Drug Discovery at Northeastern University is dedicated to designing and discovering novel medications, developing technologies, and training scientists in the multidisciplinary field of drug discovery. We are recruiting a Postdoctoral Research Associate with expertise in protein-based mass spectrometry and /or proteomics.

Product Manager - Techne, Stone, Staffordshire
Bibby Scientific
Bibby Scientific Ltd is one of the world’s leading manufacturers of Laboratory bench-top scientific equipment. For more information about the company, please visit their website (www.bibby-scientific.com).


Mass Spec Europe, Florence, Italy
09 November 2010 - 10 November 2010

Mass Spec Europe 2010, will build on the success of this years meeting, by delivering more top class speakers, giving their views and expert opinions on the latest, cutting-edge techniques being used within the mass spectrometry sector. Delegates will also benefit three other conferences which it is being co-located with, ensuring a cost effective trip.

European Biomarkers Summit, 9-10 November 2010, Florence, Italy
09 November 2010 - 10 November 2010

Next years European Biomarkers Summit will be held in the beautiful city of Florence, Italy and will bring further updates on the use of biomarkers within disease diagnosis and prevention, by focussing on biomarkers within areas such as metabolomics, genomics and traditional medicine.

Advances in Metabolic Profiling, Florence, Italy
09 November 2010 - 10 November 2010

Welcome to the 6th annual Advances in Metabolic Profiling conference and exhibition.
This year's event will be held in the beautiful and historic city of Florence.
The conference will be co-located with Mass Spec Europe, European Biomarkers Summit and Advances in Protein Crystallography. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

  

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Cancer Personalized Medicine 2008
Published July 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i

Novel ProteoPrep® 20 Immunoaffinity Depletion Resin for Human Plasma
Sigma Aldrich

Sigma’s ProteoPrep® 20 Plasma Immunodepletion Kit specifically removes 20 of the most abundant proteins from human plasma or serum in preparation for two-dimensional electrophoresis. The technology specifically removes twenty of the top high abundance proteins utilizing conventional antibodies coupled with small recombinant immunoaffinity ligands. The ProteoPrep 20 technology is advancing the frontier of biomarker discovery.